ArticleResearch (Washington, D.C.)2026

Novel Combination of Irreversible Electroporation and Allogenic Chimeric Antigen Receptor T-Cell Therapy Synergizes Therapeutic Outcomes in a Preclinical Human Pancreatic Cancer Mouse Model.

Edward Jacobs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.